Fenofibrate for liver cirrhosis, biliary

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jan 2024: Trial started, NCT06755151
  2. 1 Jan 2025: Trial registered, NCT06755151

The trials

NCT06755151: Fenofibrate in Primary Biliary Cholangitis: a Real World Study

State
Under way
Phase
Phase 3
People
300 planned
Started
17 Jan 2024
Primary completion
Dec 2035
Arms
fenofibrate
Results
None posted
  1. 17 Jan 2024: Trial started
  2. 1 Jan 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Antara, Fenoglide, Lipantil, Lipidil, Lipofen, Tricor, Triglide.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.